Pilot study of gemcitabine (G) plus trastuzumab (H) in metastatic breast cancer patients with erb-2 overexpression previously treated with anthracyclines (A) and taxanes (T)

L.Cirera Nogueras; Galán; M.Mu?oz; B.Martinez; L.Calvo; M.A.Segui; A.Oltra; J.M.García; S.González

首页> 外文期刊>European Journal of Cancer Supplements >Pilot study of gemcitabine (G) plus trastuzumab (H) in metastatic breast cancer patients with erb-2 overexpression previously treated with anthracyclines (A) and taxanes (T)

【24h】

Pilot study of gemcitabine (G) plus trastuzumab (H) in metastatic breast cancer patients with erb-2 overexpression previously treated with anthracyclines (A) and taxanes (T)

机译：吉西他滨（G）加曲妥珠单抗（H）在先前用蒽环类药物（A）和紫杉烷类药物（T）治疗的转移性erb-2过表达的乳腺癌患者中的初步研究

获取原文

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2006年第2期|共1页
作者
L.Cirera Nogueras; Galán; M.Mu?oz; B.Martinez; L.Calvo; M.A.Segui; A.Oltra; J.M.García; S.González;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. A phase II study of trastuzumab emtansine in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer who were previously treated with trastuzumab, lapatinib, an anthracycline, a taxane, and capecitabine [J] . KropI.E., LoRussoP., MillerK.D., Journal of Clinical Oncology . 2012,第26期

机译：曲妥珠单抗Emtansine对人类表皮生长因子受体2阳性转移性乳腺癌患者的II期研究，该患者先前曾接受过曲妥珠单抗，拉帕替尼，蒽环类，紫杉烷和卡培他滨治疗
2. Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial. [J] . Martin M, Ruiz A, Munoz M, The lancet oncology . 2007,第3期

机译：吉西他滨联合长春瑞滨与长春瑞滨单药治疗以前用蒽环类和紫杉烷类药物治疗的转移性乳腺癌患者：西班牙乳腺癌研究小组（GEICAM）III期试验的最终结果。
3. A phase 2 study of the combination of gemcitabine and cisplatin in patients with locally advanced or metastatic breast cancer previously treated with anthracyclines with/without taxanes [J] . Hanna Kohail, Samir Shehata, Omar Mansour, Hematology/Oncology and Stem Cell Therapy . 2012,第1期

机译：吉西他滨和顺铂联合治疗先前接受蒽环类药物联合/不联合紫杉类药物治疗的局部晚期或转移性乳腺癌患者的2期研究
4. Clinical implications of HER-2 and p53 in taxane-based and anthracycline-based neoadjuvant chemotherapy in breast cancer [C] . World congress on breast diseases . 2008

机译：HER-2和P53在紫杉烷基和蒽环类新辅助化疗的乳腺癌中的临床意义
5. Utilities of metastatic breast cancer patients treated with taxanes compared to utilities of oncology nurses. [D] . Hauser, Robert Sean. 2001

机译：与肿瘤科护士相比，使用紫杉烷类治疗的转移性乳腺癌患者的效用。
6. Phase II study of capecitabine and trastuzumab combination chemotherapy in patients with HER2 overexpressing metastatic breast cancers resistant to both anthracyclines and taxanes [O] . Takanori Ishida, Takayoshi Kiba, Motohiro Takeda, -1

机译：卡培他滨和曲妥珠单抗联合化疗在HER2高表达对蒽环类和紫杉烷类耐药的转移性乳腺癌患者中的II期研究
7. A phase 2 study of the combination of gemcitabine and cisplatin in patients with locally advanced or metastatic breast cancer previously treated with anthracyclines with/without taxanes [O] . Kohail Hanna, Shehata Samir, Mansour Omar, 2012

机译：吉西他滨和顺铂联合治疗先前用蒽环类药物联合/不联合紫杉类药物治疗的局部晚期或转移性乳腺癌患者的2期研究

Pilot study of gemcitabine (G) plus trastuzumab (H) in metastatic breast cancer patients with erb-2 overexpression previously treated with anthracyclines (A) and taxanes (T)

著录项

引文网络

相似文献

相关主题

期刊订阅